Revolutionizing Drug Discovery and Delivery
If you had to guess how long it takes for a drug to go from an idea to your pharmacy, what would...
We are in the midst of a healthspan revolution that will enable us to live vitally beyond 100 years old.
Advanced diagnostics are now able to catch any disease at inception, while advanced therapies in clinical trials have the potential to reverse disease while also slowing, stopping, and potentially even reversing aging.
I designed Longevity Guidebook as an easy to use roadmap to help you understand the power of this healthspan revolution (driven by AI, CRISPR, gene therapy, and cellular medicine) and to inspire you to maintain your best health to intercept the transformative breakthroughs coming this decade.
"Essential reading for anyone looking for a better tomorrow."
"If you read one business book in the twenty-first century, this should be the one."
"This is a manual for today’s big thinkers to become tomorrow’s bold leaders"
In their latest best-seller Tony Robbins, along with dr. Peter Diamandis & dr. Robert Hariri empowers you to become the CEO of your own health, happiness, and vitality through breakthroughs in precision medicine.
Tony Robbins Is An Entrepreneur, #1 New York Times Bestselling Author, And Philanthropist Honored By Accenture As One Of The Top 50 Business Intellectuals In The World. Robbins Is A Leader Called Upon By Leaders: He's Consulted And Coached Some Of The World's Greatest Athletes, Entertainers, Fortune 500 CEOs, And Four US Presidents. Robbins Is A Founder, Partner, Or Early Investor In 100+ Privately Held Businesses With Combined Sales Exceeding $7 Billion Annually.
In this gripping and insightful roadmap to our near future, Diamandis and Kotler investigate how wave after wave of exponentially accelerating technologies will impact both our daily lives and society as a whole.
What happens as AI, robotics, virtual reality, digital biology, and sensors crash into 3D printing, blockchain, and global gigabit networks? How will these convergences transform today’s legacy industries? What will happen to the way we raise our kids, govern our nations, and care for our planet?
This radical, how-to guide for using exponential technologies, moonshot thinking, and crowd-powered tools, BOLD unfolds in three parts.
Part One focuses on the exponential technologies that are disrupting today’s Fortune 500 companies and enabling upstart entrepreneurs. Part Two draws on insights from billionaires such as Larry Page, Elon Musk, Richard Branson, and Jeff Bezos and reveals their entrepreneurial secrets. Finally, BOLD closes with a look at the best practices that allow anyone to leverage today’s hyper-connected crowd like never before.
BOLD enables individuals and entrepreneurs to make their boldest dreams come true.
In Abundance, space entrepreneur turned innovation pioneer Peter H. Diamandis and award-winning science writer Steven Kotler document how progress in artificial intelligence, robotics, digital manufacturing synthetic biology, and other exponentially growing technologies will enable us to make greater gains in the next two decades than we have in the previous 200 years.
We will soon have the ability to meet and exceed the basic needs of every person on the planet. Abundance for all is within our grasp.
Peter Diamandis was the son of hardworking immigrants who wanted their science prodigy to make the family proud and become a doctor. But from the age of eight, when he watched Apollo 11 land on the Moon, his singular goal was to get to space. When he realized NASA was winding down manned space flight, Diamandis set out on one of the great entrepreneurial adventure stories of our time. If the government wouldn’t send him to space, he would create a private space flight industry himself.
The story of the bullet-shaped SpaceShipOne, and the other teams in the hunt, is an extraordinary tale of making the impossible possible.
The latest insights on exponential technologies and entrepreneurship delivered straight to your inbox.
If you had to guess how long it takes for a drug to go from an idea to your pharmacy, what would...